Eisai Parades Pipeline Before Investors During First US R&D Day

Management highlighted Eisai’s neurology and oncology assets during a Scientific Day in New York, the first formal R&D briefing the Japanese pharma’s US subsidiary has held in more than 20 years operating in the country.

Eisai Inc. – the US subsidiary of Tokyo-based Eisai Co. Ltd. – showcased its neurology and oncology pipeline during a Scientific Day in New York June 29, the first formal R&D overview the company has hosted in the US since Eisai Inc. was officially established in 1995.

“Why this time?” asked Haruo Naito, CEO of the Japanese parent, opening the four-hour briefing. “We have just launched our...